1813P - The effect of increasing doses of pegfilgrastim (Peg) on thrombocytopenia (T) in breast cancer (BC) patients (pts) receiving taxotere (Doc), doxorubicin, cyclophosphamide (TAC) and plinabulin (Plin)

Autor:	Blayney, D.W. 1, Bondarenko, I. 2, Shi, Y. 3, Ogenstad, S. 4, Du, L. 5, Huang, L. 6, Mohanlal, R. 7
Zdroj:	In Annals of Oncology October 2019 30 Supplement 5:v737-v737
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu